546 (Memantine Hydrochloride Extended Release 7 mg)
Pill with imprint 546 is White, Capsule-shape and has been identified as Memantine Hydrochloride Extended Release 7 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 7 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 546
Memantine Hydrochloride Extended Release
- Imprint
- 546
- Strength
- 7 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0546
- Inactive Ingredients
-
ammonia,
alcohol,
butyl alcohol,
ethylcellulose (7 mPa.s),
gelatin,
hypromelloses,
ferrosoferric oxide,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
triethyl citrate,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "546"
More about memantine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (64)
- Drug images
- Pricing & coupons
- En español
- Drug class: miscellaneous central nervous system agents
Patient resources
- Drug Information
- Memantine (Advanced Reading)
- Memantine Extended-Release Capsules
- Memantine Tablets
- Memantine Solution
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.